4.5 Review

Epigenetic dysregulation in cognitive disorders

Journal

EUROPEAN JOURNAL OF NEUROSCIENCE
Volume 30, Issue 1, Pages 1-8

Publisher

WILEY
DOI: 10.1111/j.1460-9568.2009.06787.x

Keywords

epigenetic codes; neurodegeneration; neurodevelopment; reversibility; schizophrenia

Categories

Funding

  1. University of Zurich
  2. Swiss Federal Institute of Technology
  3. Swiss National Science Foundation
  4. National Center for Competence in Research
  5. Human Frontier Science Program, EMBO
  6. Novartis Research Foundation
  7. Slack-Gyr Foundation

Ask authors/readers for more resources

Epigenetic mechanisms are not only essential for biological functions requiring stable molecular changes such as the establishment of cell identity and tissue formation, they also constitute dynamic intracellular processes for translating environmental stimuli into modifications in gene expression. Over the past decade it has become increasingly clear that both aspects of epigenetic mechanisms play a pivotal role in complex brain functions. Evidence from patients with neurodegenerative and neurodevelopmental disorders such as Alzheimer's disease and Rett syndrome indicated that epigenetic mechanisms and chromatin remodeling need to be tightly controlled for proper cognitive functions, and their dysregulation can have devastating consequences. However, because they are dynamic, epigenetic mechanisms are also potentially reversible and may provide powerful means for pharmacological intervention. This review outlines major cognitive disorders known to be associated with epigenetic dysregulation, and discusses the potential of 'epigenetic medicine' as a promising cure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available